Mostrar el registro sencillo del ítem

dc.contributor.authorGómez Carballa, Alberto
dc.contributor.authorBello Paderne, Xabier
dc.contributor.authorPardo Seco, Jacobo José
dc.contributor.authorMartinón Torres, Federico 
dc.contributor.authorSalas Ellacuriaga, Antonio
dc.date.accessioned2022-04-26T07:42:30Z
dc.date.available2022-04-26T07:42:30Z
dc.date.issued2020
dc.identifier.issn1088-9051
dc.identifier.otherhttps://www.ncbi.nlm.nih.gov/pubmed/32878977es
dc.identifier.urihttp://hdl.handle.net/20.500.11940/16511
dc.description.abstractThe human pathogen severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is responsible for the major pandemic of the twenty-first century. We analyzed more than 4700 SARS-CoV-2 genomes and associated metadata retrieved from public repositories. SARS-CoV-2 sequences have a high sequence identity (>99.9%), which drops to >96% when compared to bat coronavirus genome. We built a mutation-annotated reference SARS-CoV-2 phylogeny with two main macro-haplogroups, A and B, both of Asian origin, and more than 160 sub-branches representing virus strains of variable geographical origins worldwide, revealing a rather uniform mutation occurrence along branches that could have implications for diagnostics and the design of future vaccines. Identification of the root of SARS-CoV-2 genomes is not without problems, owing to conflicting interpretations derived from either using the bat coronavirus genomes as an outgroup or relying on the sampling chronology of the SARS-CoV-2 genomes and TMRCA estimates; however, the overall scenario favors haplogroup A as the ancestral node. Phylogenetic analysis indicates a TMRCA for SARS-CoV-2 genomes dating to November 12, 2019, thus matching epidemiological records. Sub-haplogroup A2 most likely originated in Europe from an Asian ancestor and gave rise to subclade A2a, which represents the major non-Asian outbreak, especially in Africa and Europe. Multiple founder effect episodes, most likely associated with super-spreader hosts, might explain COVID-19 pandemic to a large extent.en
dc.rightsAtribución-NoComercial 4.0 Internacional
dc.rights.urihttp://creativecommons.org/licenses/by-nc/4.0/
dc.subject.meshPhylogeny*
dc.subject.meshBase Sequence*
dc.subject.meshChiroptera*
dc.subject.meshPandemics*
dc.subject.meshGenome*
dc.subject.meshChromosome Mapping*
dc.subject.meshCoronavirus Infections*
dc.subject.meshGenetic Variation*
dc.subject.meshPneumonia*
dc.subject.meshAnimals*
dc.subject.meshHumans*
dc.subject.meshPhylogeography*
dc.subject.meshSequence Homology*
dc.titleMapping genome variation of SARS-CoV-2 worldwide highlights the impact of COVID-19 super-spreadersen
dc.typeJournal Articlees
dc.authorsophosGómez-Carballa, A.;Bello, X.;Pardo-Seco, J.;Martinón-Torres, F.;Salas, A.
dc.identifier.doi10.1101/gr.266221.120
dc.identifier.pmid32878977
dc.identifier.sophos39095
dc.issue.number10es
dc.journal.titleGENOME RESEARCHes
dc.organizationServizo Galego de Saúde::Estrutura de Xestión Integrada (EOXI)::EOXI de Santiago de Compostela - Complexo Hospitalario Universitario de Santiago de Compostela::Pediatríaes
dc.organizationServizo Galego de Saúde::Estrutura de Xestión Integrada (EOXI)::Instituto de Investigación Sanitaria de Santiago de Compostela (IDIS)es
dc.page.initial1434es
dc.page.final1448es
dc.rights.accessRightsopenAccess
dc.subject.decshomología de secuencias*
dc.subject.decsanimales*
dc.subject.decsvariación genética*
dc.subject.decsmapeo cromosómico*
dc.subject.decsgenoma*
dc.subject.decspandemias*
dc.subject.decsChiroptera*
dc.subject.decsfilogeografía*
dc.subject.decssecuencia de bases*
dc.subject.decsneumonía*
dc.subject.decsfilogenia*
dc.subject.decshumanos*
dc.subject.decsinfecciones por Coronavirus*
dc.subject.keywordCHUSes
dc.subject.keywordIDISes
dc.typefidesArtículo Originales
dc.typesophosArtículo Originales
dc.volume.number30es


Ficheros en el ítem

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Atribución-NoComercial 4.0 Internacional
Excepto si se señala otra cosa, la licencia del ítem se describe como Atribución-NoComercial 4.0 Internacional